Market Insights Health Hospitals Inpatient Care

Neoplasm Treatment - United Kingdom

United Kingdom

In the United Kingdom, the Neoplasm Treatment market is expected to experience significant growth in the coming years.
According to projections, the revenue in this market is projected to reach €6.97bn by 2024.
Furthermore, there is an anticipated annual growth rate (CAGR 2024-2029) of 7.59%, which will lead to a market volume of €10.05bn by 2029.
When compared globally, it is worth noting that in the United States is expected to generate the highest revenue in the Neoplasm Treatment market.
In 2024 alone, the revenue in the United States is projected to reach an impressive €83.98bn.
The United Kingdom is at the forefront of innovative neoplasm treatment research and development.

Key regions: Europe, Canada, Brazil, United States, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.